In 2020, Huang et al. indicated that Raf kinase inhibitor protein (RKIP) exerts its inhibitory effect on NRF/NQO1 through upregulating miR-450b-5p, which binds and inhibits Nrf2 in NPC directly. The gene discussed is PEBP1; the disease is nasopharyngeal carcinoma.